Next Article in Journal
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (“PEMBROREAL” Study)
Previous Article in Journal
Current Status and Future Perspectives of Antibody–Drug Conjugates in Hormone Receptor-Positive Breast Cancer
Previous Article in Special Issue
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation
 
 
Article

Article Versions Notes

Cancers 2024, 16(10), 1803; https://doi.org/10.3390/cancers16101803
Action Date Notes Link
article pdf uploaded. 8 May 2024 15:18 CEST Version of Record https://www.mdpi.com/2072-6694/16/10/1803/pdf-vor
article xml file uploaded 13 May 2024 06:30 CEST Original file -
article xml uploaded. 13 May 2024 06:30 CEST Update https://www.mdpi.com/2072-6694/16/10/1803/xml
article pdf uploaded. 13 May 2024 06:30 CEST Updated version of record https://www.mdpi.com/2072-6694/16/10/1803/pdf
article html file updated 13 May 2024 06:32 CEST Original file https://www.mdpi.com/2072-6694/16/10/1803/html
Back to TopTop